Platelet reactivity linked to risks in endovascular procedures

05/1/2013 | Healio

A study in the Journal of the American College of Cardiology found that increased on-treatment platelet reactivity was tied to a greater risk of adverse clinical events with peripheral endovascular procedures. Basing antiplatelet treatment levels on point-of-care tests could lead to better outcomes for patients, the authors said.

View Full Article in:

Healio

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Food & Drug Associate
Confidential
Washington, D.C., DC
Senior Manager, Gaps in Care
UAW Retiree Medical Benefits Trust
Detroit, MI
Compliance Director
Abbott Laboratories
Santa Clara, CA
Junior to Mid-Level FDA Associate
Morgan Lewis
Washington, DC
Product Development Manager, Disposable Medical Products
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA